首页 | 本学科首页   官方微博 | 高级检索  
   检索      


The residual deoxycytidine phosphorylating activity of thymidine kinase 2 may determine differences in clinical manifestations of thymidine kinase 2 deficiency
Authors:Marjan Amiri  Nicola Solaroli  Anna Karlsson
Institution:Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, S-141 86 Stockholm, Sweden;Department of Experimental Therapeutics and Grace Cancer Drug Center, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, N.Y. 14263 U.S.A.;Division of Experimental Virology, Institute for Medical Microbiology, Johannes Gutenberg-University, D-6500 Mainz G.F.R.;Institute of Pathology, University of Munich, Munich F.R.G.;Department of Pharmacology, University of Kansas Medical Center, College of Health Sciences and Hospital, Kansas City, KS 66103, U.S.A.;Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号